Age: 18-75
Condition: Uncontrolled, Type 2 Diabetics currently using Semaglutide or Tirzepatide for at least 3 months. A1c 7.5-10.5.
Study length: 6 months with 11 office visits.
Provided: Study related labs, physicals and testing as well as your Semaglutide or Tirzepatide along with an investigational diabetic medication. Compensation for all study visits.
Insurance is not needed.
Call 317-297-7999 x 3 or click the enroll today